| answer text |
<p>The Antivirals and Therapeutics Taskforce has regular engagement with international
partners to share learning on the use, deployment and evaluation of therapeutics and
antivirals, including Evusheld. The Taskforce recently met with counterparts from
the United States of America and discussed the recent change to the Food and Drug
Administration’s treatment guidelines, which recommends physicians advise individuals
to have appropriate alternate treatment plans in place, should emerging COVID-19 variants
be resistant to Evusheld.</p><p>We continue monitoring whether and how other countries
are using pre-exposure prophylactic treatments in people who are moderately to severely
immunocompromised.</p>
|
 |
